You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
"Best Provider" Winner,
2019 Waters Rankings Awards:
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.
At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.
WindRose Health Investors raises $705M for 5th fund at closing
Banking Essentials Newsletter - November Edition
University Essentials | COVID-19 Economic Outlook in Banking: Rates and Long-Term Expectations: Q&A with the Experts
Estimating Credit Losses Under COVID-19 and the Post-Crisis Recovery
StreetTalk – Episode 70: Banks' Liquidity Conundrum Could Fuel M&A Activity
WindRose Health Investors LLC pulled in $705 million for its fifth fund at closing.
The Windrose Health Investors V LP fund will invest in businesses focused on the healthcare services sector. Weil Gotshal & Manges LLP was legal counsel in the formation of the fund.
New York City-based WindRose manages more than $1.4 billion of capital and backs healthcare companies across the U.S.